Pepgen announces upcoming data presentations at the 2023 annual muscle dystrophy association clinical and scientific conference

Boston, march 13, 2023 (globe newswire) -- pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that it will present at the muscular dystrophy association (mda) annual clinical and scientific conference, taking place on march 19-22, 2023 in dallas, texas.
PEPG Ratings Summary
PEPG Quant Ranking